Kimberly Long

873 total citations
17 papers, 626 citations indexed

About

Kimberly Long is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kimberly Long has authored 17 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kimberly Long's work include Muscle Physiology and Disorders (7 papers), Neurogenetic and Muscular Disorders Research (4 papers) and RNA regulation and disease (2 papers). Kimberly Long is often cited by papers focused on Muscle Physiology and Disorders (7 papers), Neurogenetic and Muscular Disorders Research (4 papers) and RNA regulation and disease (2 papers). Kimberly Long collaborates with scholars based in United States, Australia and Canada. Kimberly Long's co-authors include Grace K. Pavlath, Luciano H. Apponi, Monty Montano, Kelly Howell, W.K. Seow, Tom C. Hart, Michael J. Aldred, J. Timothy Wright, P J Crawford and Micah T. Webster and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Journal of Cell Science.

In The Last Decade

Kimberly Long

17 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kimberly Long United States	13	452	184	112	112	92	17	626
Qiming Zhai China	10	222 0.5×	144 0.8×	57 0.5×	54 0.5×	71 0.8×	15	489
Yougen Xi United States	9	442 1.0×	86 0.5×	91 0.8×	42 0.4×	141 1.5×	9	767
Aurélie Guguin France	7	498 1.1×	221 1.2×	27 0.2×	287 2.6×	93 1.0×	7	912
Sarah Beckman United States	12	263 0.6×	163 0.9×	28 0.3×	198 1.8×	42 0.5×	16	540
David R. Deyle United States	15	477 1.1×	93 0.5×	71 0.6×	203 1.8×	53 0.6×	34	955
John R. Glossop United Kingdom	16	281 0.6×	104 0.6×	184 1.6×	75 0.7×	53 0.6×	22	737
Yongchao Gou China	11	207 0.5×	150 0.8×	33 0.3×	86 0.8×	33 0.4×	23	487
Simona Corrao Italy	14	366 0.8×	564 3.1×	44 0.4×	447 4.0×	45 0.5×	29	958
Anna Valeria Samarelli Italy	15	211 0.5×	206 1.1×	24 0.2×	137 1.2×	59 0.6×	22	642
Olfa Ghali France	7	209 0.5×	93 0.5×	66 0.6×	43 0.4×	44 0.5×	7	440

Countries citing papers authored by Kimberly Long

Since Specialization

Citations

This map shows the geographic impact of Kimberly Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Long more than expected).

Fields of papers citing papers by Kimberly Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Long. The network helps show where Kimberly Long may publish in the future.

Co-authorship network of co-authors of Kimberly Long

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Long. A scholar is included among the top collaborators of Kimberly Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Long. Kimberly Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Day, John, Kelly Howell, Kimberly Long, et al.. (2022). Advances and limitations for the treatment of spinal muscular atrophy. BMC Pediatrics. 22(1). 632–632. 61 indexed citations

Barrett, D, Sanela Bilic, Yung Chyung, et al.. (2021). A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy. Advances in Therapy. 38(6). 3203–3222. 30 indexed citations

Chen, Valerie, et al.. (2020). When weighing universal precautions, filtration efficiency is not universal. Journal of Hospital Infection. 105(3). 412–413. 3 indexed citations

Kalra, Ashish, Shaun Cote, D Barrett, et al.. (2019). P.126SRK-015, a fully human monoclonal antibody inhibiting myostatin activation, offers sustained target engagement across multiple species, including humans. Neuromuscular Disorders. 29. S85–S85. 3 indexed citations

Pirruccello, Michelle, Justin Jackson, Stefan Wawersik, et al.. (2018). Blocking extracellular activation of myostatin as a strategy for treating muscle wasting. Scientific Reports. 8(1). 2292–2292. 71 indexed citations

Long, Kimberly, Karen M. O’Shea, Ramzi J. Khairallah, et al.. (2018). Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy. Human Molecular Genetics. 28(7). 1076–1089. 82 indexed citations

Nakai, Takashi, Nicholas R. Perl, Timothy C. Barden, et al.. (2016). Discovery of IWP-051, a Novel Orally Bioavailable sGC Stimulator with Once-Daily Dosing Potential in Humans. ACS Medicinal Chemistry Letters. 7(5). 465–469. 24 indexed citations

Kusko, Rebecca, Kimberly Long, Jeffrey S. Otis, et al.. (2012). Premature expression of a muscle fibrosis axis in chronic HIV infection. Skeletal Muscle. 2(1). 10–10. 24 indexed citations

Neubert, Hendrik, Scott Fountain, Lindsay King, et al.. (2012). Tissue Bioanalysis of Biotherapeutics And Drug Targets to Support Pk/Pd. Bioanalysis. 4(21). 2589–2604. 26 indexed citations

10.

Wright, J. Timothy, Kimberly Long, W.K. Seow, et al.. (2011). Amelogenesis Imperfecta: Genotype-Phenotype Studies in 71 Families. Cells Tissues Organs. 194(2-4). 279–283. 96 indexed citations

11.

Long, Kimberly, et al.. (2010). The RNA Editor Gene ADAR1 is Induced in Myoblasts by Inflammatory Ligands and Buffers Stress Response. Clinical and Translational Science. 3(3). 73–80. 17 indexed citations

12.

Montano, Monty & Kimberly Long. (2010). RNA surveillance—An emerging role for RNA regulatory networks in aging. Ageing Research Reviews. 10(2). 216–224. 15 indexed citations

13.

Apponi, Luciano H., et al.. (2010). Chemokine expression and control of muscle cell migration during myogenesis. Journal of Cell Science. 123(18). 3052–3060. 117 indexed citations

14.

Long, Kimberly, Monty Montano, & Grace K. Pavlath. (2010). Sca‐1 is negatively regulated by TGF‐βlin myogenic cells. The FASEB Journal. 25(4). 1156–1165. 20 indexed citations

15.

Long, Kimberly, Grace K. Pavlath, & Monty Montano. (2010). Sca-1 influences the innate immune response during skeletal muscle regeneration. American Journal of Physiology-Cell Physiology. 300(2). C287–C294. 11 indexed citations

16.

Simmons, Darrin, et al.. (2009). WNT5A Expression in Ameloblastoma and Its Roles in Regulating Enamel Epithelium Tumorigenic Behaviors. American Journal Of Pathology. 176(1). 461–471. 24 indexed citations

17.

Long, Kimberly, et al.. (1997). Autonomic Dysreflexia and Boosting in Wheelchair Athletes. Adapted Physical Activity Quarterly. 14(3). 203–209. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact